BioMADE chooses Minnesota as hub for its biotech initiatives

In Minnesota, BioMADE announced Maple Grove as the Minnesota site in its national network of bioindustrial manufacturing infrastructure. The facility will further establish the U.S. as a leader in biotechnology and biomanufacturing, support national security initiatives, boost economic opportunity, increase markets for farmers, and bring well-paying manufacturing jobs to the region. 

Located at 7500 Meridian Circle North, the 122,000 square foot facility will feature demonstration-scale piloting equipment, with two 25,000-liter industrial fermenters, allowing innovative companies of all sizes to take their processes to the next level as they march toward full-scale commercial manufacturing. The project represents an investment of at least $132M, with funding provided by the U.S. Department of Defense and the Minnesota Department of Employment and Economic Development.